0.00Open0.00Pre Close0 Volume0 Open Interest20.00Strike Price0.00Turnover149.66%IV-53.29%PremiumDec 20, 2024Expiry Date22.82Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9839Delta0.0024Gamma1.87Leverage Ratio-0.0154Theta0.0131Rho1.84Eff Leverage0.0045Vega
Federated Hermes Stock Discussion
• $Cadence Design Systems (CDNS.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $175 (from $160)
• $Federated Hermes (FHI.US)$ : KBW Upgrades to Outperform from Market Perform - PT $540
• $Goldman Sachs (GS.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $380 (from $360)
• $McDonald's (MCD.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $278 (from $245)
• $Oracle (ORCL.US)$ : Exane Upg...
• $Actinium (ATNM.US)$ +30.81% (Actinum Pharma and Immedica to commercialize lomab-B (1311 apamistamab) in Europe the Middle East and North Africa)
• $Aeglea BioTherapeutics (AGLE.US)$ +18.11% (presents additional data from PEACE phase 3 study of Pegzilarginase; submits BLA to FDA for Pegzilarginase)
• $Grid Dynamics (GDYN.US)$ +5% (expands in Europe ceases operations in Russia)
• $Artisan Partners Asset Management (APAM.US)$ +4....
No comment yet